605 related articles for article (PubMed ID: 32926272)
21. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
23. [Cardiovascular implications of SARS-CoV-2 infection: A literature review].
García-Saavedra MB; Rosales-Gutiérrez RR; Valverde E; Chumbes-Aguirre M; Alvarado R; Polo R; Azañero R; Chávez C
Medwave; 2020 Aug; 20(7):e8008. PubMed ID: 32877391
[TBL] [Abstract][Full Text] [Related]
24. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
Seltzer S
Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and Cardiovascular Disease: A Comprehensive Review.
Khalil F; Oleszak F; Stys T; Stys A
S D Med; 2022 Feb; 75(2):54-60. PubMed ID: 35704865
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
27. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
[TBL] [Abstract][Full Text] [Related]
28. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
29. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
30. Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection.
Paul D; Mohankumar SK; Thomas RS; Kheng CB; Basavan D
Curr Drug Targets; 2022; 23(4):364-372. PubMed ID: 34732115
[TBL] [Abstract][Full Text] [Related]
31. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Barkas F; Milionis H; Anastasiou G; Liberopoulos E
Med Hypotheses; 2021 Jan; 146():110452. PubMed ID: 33333472
[TBL] [Abstract][Full Text] [Related]
32. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19.
Dou Q; Wei X; Zhou K; Yang S; Jia P
Trends Endocrinol Metab; 2020 Dec; 31(12):893-904. PubMed ID: 33172748
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
35. The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Zhu H; Zhang L; Ma Y; Zhai M; Xia L; Liu J; Yu S; Duan W
J Cell Mol Med; 2021 Feb; 25(3):1342-1349. PubMed ID: 33443816
[TBL] [Abstract][Full Text] [Related]
36. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
37. COVID-19: Between Past and Present.
Assaf AM; Haddadin RN; Akour AA
Viral Immunol; 2021 Apr; 34(3):145-157. PubMed ID: 33017280
[TBL] [Abstract][Full Text] [Related]
38. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu Y; Liu L; Lu X
Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]